Fragment Length of Circulating Tumor DNA.
Malignant tumors shed DNA into the circulation. The transient half-life of circulating tumor DNA (ctDNA) may afford the opportunity to diagnose, monitor recurrence, and evaluate response to therapy solely through a non-invasive blood draw. However, detecting ctDNA against the normally occurring back...
Päätekijät: | , , , , , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Public Library of Science (PLoS)
2016-07-01
|
Sarja: | PLoS Genetics |
Linkit: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1006162&type=printable |